The limited regulatory potential of medical technology assessment.
作者信息
Elhauge E
机构信息
Harvard Law School, USA.
出版信息
Va Law Rev. 1996 Nov;82(8):1525-1622.
PMID:16715565
Abstract
摘要
相似文献
1
The limited regulatory potential of medical technology assessment.医学技术评估有限的监管潜力。
Va Law Rev. 1996 Nov;82(8):1525-1622.
2
Does assessment of medical practices have a future?对医疗实践的评估有未来吗？
Va Law Rev. 1996 Nov;82(8):1623-40.
3
Medicare and cost-effectiveness analysis.医疗保险与成本效益分析。
N Engl J Med. 2005 Oct 6;353(14):1516-22. doi: 10.1056/NEJMsb050564.
4
Reflections on science, judgment, and value in evidence-based decision making: a conversation with David Eddy by Sean R. Tunis.循证决策中的科学、判断与价值之思考：肖恩·R·图尼斯与大卫·埃迪的对话
Health Aff (Millwood). 2007 Jul-Aug;26(4):w500-15. doi: 10.1377/hlthaff.26.4.w500. Epub 2007 Jun 19.
5
Review of medical technology policies shows need, opportunities for changes.医学技术政策审查显示出变革的必要性和机遇。
Hospitals. 1982 Apr 1;56(7):87-90.
6
Reimbursing new technologies: why are the courts judging experimental medicine?新技术的报销问题：为何法院要对实验性医学进行评判？
Stanford Law Rev. 1992 May;44(5):1095-131.
7
The heart transplant dilemma.心脏移植困境
Issues Sci Technol. 1986 Spring;2(3):91-101.
8
Health industry waiting for final rules revamping Medicare coverage policy.
Mod Healthc. 1991 Jan 28;21(4):22.
9
Role of technology assessment in health benefits coverage for medical devices.技术评估在医疗设备健康效益覆盖中的作用。
Am J Manag Care. 1998 Sep 25;4 Spec No:SP139-50.
10
Evaluating new medical technology: science or politics?
HMO. 1995 Jul-Aug;36(4):48-53.
Zotero 插件